The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2006

Filed:

Jun. 04, 2003
Applicants:

Jacquelyn Sampson, College Park, GA (US);

Harold Russell, Efland, NC (US);

Jean A. Tharpe, Lithonia, GA (US);

Edwin W. Ades, Atlanta, GA (US);

George M. Carlone, Stone Mountain, GA (US);

Inventors:

Jacquelyn Sampson, College Park, GA (US);

Harold Russell, Efland, NC (US);

Jean A. Tharpe, Lithonia, GA (US);

Edwin W. Ades, Atlanta, GA (US);

George M. Carlone, Stone Mountain, GA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/40 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides a nucleic acid encoding the 37-kDa protein from. Also provided are isolated nucleic acids comprising a unique fragment of at least 10 nucleotides of the 37-kDa protein. The invention also provides purified polypeptides encoded by the nucleic acid encoding the 37-kDa protein from and the nucleic acids comprising a unique fragment of at least 10 nucleotides of the 37-kDa protein. Also provided are antibodies which selectively binds the polypeptides encoded by the nucleic acid encoding the 37-kDa protein and the nucleic acids comprising a unique fragment of at least 10 nucleotides of the 37-kDa protein. Also provided are vaccines comprising immunogenic polypeptides encoded by the nucleic acid encoding the 37-kDa protein and the nucleic acids comprising a unique fragment of at least 10 nucleotides of the 37-kDa protein. Further provided is a method of detecting the presence ofin a sample comprising the steps of contacting a sample suspected of containingwith nucleic acid primers capable of hybridizing to a nucleic acid comprising a portion of the nucleic acid encoding the 37-kDa protein, amplifying the nucleic acid and detecting the presence of an amplification product, the presence of the amplification product indicating the presence ofin the sample. Further provided are methods of detecting the presence ofin a sample using antibodies or antigens, methods of preventing and treatinginfection in a subject.


Find Patent Forward Citations

Loading…